Maryam Ahmadi

Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics

Maryam Ahmadi, Christine Bryson, Edward A. Cloake et al. · Pharmaceutical Research · 2014 · 162 citations

Sub-visible Aggregates, Allergy, Monoclonal Antibody Therapeutics +10

CD3 limits the efficacy of TCR gene therapy in vivo

Maryam Ahmadi, Judith King, Shao-An Xue et al. · Blood · 2011 · 115 citations · Full text

Prevention of Both Direct and Cross-Priming of Antitumor CD8+ T-Cell Responses following Overproduction of Prostaglandin E2 by Tumor Cells<i>In vivo</i>

Maryam Ahmadi, David C. Emery, David J. Morgan · Cancer Research · 2008 · 98 citations · Full text

IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2–Mediated Inhibition of Antitumor CTL Responses

Fatemah Basingab, Maryam Ahmadi, David J. Morgan · Cancer Immunology Research · 2016 · 52 citations · Full text

Redirection to the bone marrow improves T cell persistence and antitumor functions

Anjum Khan, Ben Carpenter, Pedro Santos e Sousa et al. · Journal of Clinical Investigation · 2018 · 50 citations · Full text

Cell Therapy, Antitumor Functions, T-regulatory Cell +20